PUBBLICAZIONI CLINICA METABOLICA
Pubblicazioni 2009
Le seguenti pubblicazioni sono state pubblicate nel corso dell’anno 2009
The role of the Framingham risk score to predict the presence of subclinical coronary atherosclerosis in patients with HIV infection.
Rossi R, Nuzzo A, Guaraldi G, Orlando G, Squillace N, Ligabue G, Fiocchi F, Di Girolamo A, Romagnoli R, Modena MG.
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):303-4. doi: 10.1097/QAI.0b013e3181b18c19. No abstract available.
Coronary aging in HIV-infected patients.
Guaraldi G, Zona S, Alexopoulos N, Orlando G, Carli F, Ligabue G, Fiocchi F, Lattanzi A, Rossi R, Modena MG, Esposito R, Palella F, Raggi P.
Clin Infect Dis. 2009 Dec 1;49(11):1756-62. doi: 10.1086/648080.
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men.
Lo Re V 3rd, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, Tebas P.
AIDS. 2009 Oct 23;23(16):2191-8. doi: 10.1097/QAD.0b013e32832ec258.
Detectable HIV viral load is associated with metabolic syndrome.
Squillace N, Zona S, Stentarelli C, Orlando G, Beghetto B, Nardini G, Esposito R, Guaraldi G.
J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):459-64. doi: 10.1097/QAI.0b013e3181b93a23. Erratum in: J Acquir Immune Defic Syndr. 2010 Mar 1;53(3):424.
Differential dose adjustments of immunosuppressants after resuming boosted versus unboosted HIV-protease inhibitors postliver transplant.
Guaraldi G, Cocchi S, Motta A, Ciaffi S, Conti C, Codeluppi M, Bonora S, Zona S, Di Benedetto F, Pinetti D, D'Avolio A, Bertolini A, Esposito R.
Am J Transplant. 2009 Oct;9(10):2429-34. doi: 10.1111/j.1600-6143.2009.02778.x. Epub 2009 Jul 28.
Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects.
Guaraldi G, Stentarelli C, Zona S, Orlando G, Carli F, Ligabue G, Lattanzi A, Zaccherini G, Rossi R, Modena MG, Alexopoulos N, Palella F, Raggi P.
Atherosclerosis. 2010 Jan;208(1):222-7. doi: 10.1016/j.atherosclerosis.2009.06.011. Epub 2009 Jun 18.
Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from lipodystrophy to non-infectious HIV co-morbidities.
Guaraldi G, Baraboutis IG.
J Antimicrob Chemother. 2009 Sep;64(3):437-40. doi: 10.1093/jac/dkp240. Epub 2009 Jul 3. Review.
Efficacy and safety of atazanavir in patients with end-stage liver disease.
Guaraldi G, Cocchi S, Motta A, Ciaffi S, Codeluppi M, Bonora S, Di Benedetto F, Masetti M, Floridia M, Baroncelli S, Pinetti D, Bertolini A, Gerunda GE, Esposito R.
Infection. 2009 Jun;37(3):250-5. doi: 10.1007/s15010-008-8025-z. Epub 2009 May 26.
Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients.
Rossi R, Nuzzo A, Guaraldi G, Squillace N, Orlando G, Esposito R, Lattanzi A, Modena MG.
Metabolism. 2009 Jul;58(7):927-33. doi: 10.1016/j.metabol.2009.02.026.
Body image is a major determinant of sexual dysfunction in stable HIV-infected women.
Luzi K, Guaraldi G, Murri R, De Paola M, Orlando G, Squillace N, Esposito R, Rochira V, Zirilli L, Martinez E.
Antivir Ther. 2009;14(1):85-92. Erratum in: Antivir Ther. 2009;14(3):465. Vincenzo, Rochira [corrected to Rochira, Vincenzo].
Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
Murri R, Guaraldi G, Lupoli P, Crisafulli R, Marcotullio S, von Schloesser F, Wu AW.
AIDS Patient Care STDS. 2009 Jan;23(1):35-9. doi: 10.1089/apc.2007.0248.
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
Guaraldi G, Ventura P, Garlassi E, Orlando G, Squillace N, Nardini G, Stentarelli C, Zona S, Marchini S, Moriondo V, Tebas P.
HIV Med. 2009 Jan;10(1):28-34. doi: 10.1111/j.1468-1293.2008.00649.x.
Heterologous fat transplantation for the treatment of HIV-related facial lipoatrophy.
Guaraldi G, Squillace N, De Fazio D, Prestileo T, Palella F.
Ann Intern Med. 2009 Jan 6;150(1):61-3. No abstract available.
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study.
Guaraldi G, Roverato A, Giovanardi C, Ravera F, Squillace N, Orlando G, Cappelli G, Esposito R, Palella F.
J Antimicrob Chemother. 2009 Feb;63(2):374-9. doi: 10.1093/jac/dkn499. Epub 2008 Dec 17.
TUTTE LE NOSTRE PUBBLICAZIONI
Siamo lieti
di accoglierti
Chiedici informazioni
o prenota la tua prima visita
presso la Clinica Metabolica
di Modena